help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 25, 2003
Endocrinology, doi:10.1210/en.2003-0547
A more recent version of this article appeared on January 1, 2004
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
145/1/113    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D.-b.
Right arrow Articles by Magness, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.-b.
Right arrow Articles by Magness, R. R.

Submitted on May 1, 2003
Accepted on September 15, 2003

Membrane estrogen receptor dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells

Dong-bao Chen1*, Ian M. Bird1, Jing Zheng1, and Ronald R. Magness1

1 Department of Reproductive Medicine, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093; Perinatal Research Laboratories, Departments of Obstetrics and Gynecology, and Animal Sciences, University of Wisconsin-Madison, 7E. Meriter Hospital, 202 S. Park Street, Madison, WI 53715

* To whom correspondence should be addressed. E-mail: dochen{at}ucsd.edu.

Rapid uterine vasodilatation following estrogen administration is believed to be mediated by endothelial production of nitric oxide (NO) via endothelial NO synthase (eNOS). However, the mechanism(s) by which estrogen activates eNOS in uterine artery endothelial cells (UAEC) is unknown. In this study, we observed that E2 and E2-BSA rapidly (<2 min) increased total NOx production in UAEC in vitro. This was associated with rapid eNOS phosphorylation and activation, but was unaltered by pretreatment with actinomycin-D. ER{alpha} protein was detectable in isolated plasma membrane proteins by immunoblotting and E2-BSA-FITC binding was evident on the plasma membrane of UAEC. E2 did not mobilize intracellular Ca2+, but E2 and ionomycin in combination induced greater eNOS phosphorylation than either E2 or ionomycin alone. E2 did not stimulate rapid Akt phosphorylation. E2 stimulated rapid ERK2/1 activation in a time- and dose-dependent manner with maximal responses observed at 5-10 min with E2 (10 nM to 1 µM) treatment. Acute activation of eNOS and NOx production by E2 could be inhibited by PD98059 but not by LY294002. When E2-BSA was applied, similar responses in NOx production, eNOS and ERK2/1 activation to these of E2 were achieved. In addition, E2 and E2-BSA induced ERK2/1 activation and ICI 182,780 could inhibit NOx production. Thus, acute activation of eNOS to produce NO in UAEC by estrogen is at least partially through an ERK pathway possibly via ER localized on the plasma membrane. This pathway may provide a novel mechanism for NO-mediated rapid uterine vasodilatation by estrogen.


Key words: Estrogen • eNOS-NO • Ca2+ • Akt • ERK2/1 • membrane ER • uterine artery endothelial cells







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society